Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1,3-Butanediol SCHEMBL659565 | 0.92 | LMNA (0.46) | LMNAALDH1A1TDP1ALOX15HSD17B10 | |
| 1,3-Butanediol SCHEMBL3883350 | 0.92 | LMNA (0.46) | LMNAALDH1A1TDP1ALOX15HSD17B10 | |
| 1,3-Butanediol SCHEMBL20537096 | 0.86 | LMNA (0.40) | LMNAALDH1A1ALOX15HSD17B10TSHR | |
| Acrylic Acid SCHEMBL11323515 | 0.84 | THRB (0.59) | THRBLMNAALDH1A1ALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL8935013 | 0.84 | THRB (0.59) | THRBLMNAALDH1A1ALOX15HSD17B10 | |
| Glycerin SCHEMBL25331899 | 0.83 | LMNA (0.56) | THRBLMNAALDH1A1TDP1ALOX15 | |
| Glycerin SCHEMBL116158 | 0.83 | LMNA (0.56) | THRBLMNAALDH1A1TDP1ALOX15 | |
| Glycerin SCHEMBL733112 | 0.83 | LMNA (0.56) | THRBLMNAALDH1A1TDP1ALOX15 | |
| Glycerin SCHEMBL3370803 | 0.83 | LMNA (0.56) | THRBLMNAALDH1A1TDP1ALOX15 | |
| Glycerin SCHEMBL4946329 | 0.83 | LMNA (0.56) | THRBLMNAALDH1A1TDP1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2134729-B1 | FLUOROCHEMICAL COMPOUNDS HAVING PENDENT SILYL GROUPS | 3M INNOVATIVE PROPERTIES CO (US) | 2013-12-04 | — | — | EP | disclosed |
| US-7825272-B2 | Fluorochemical urethane compounds having pendent silyl groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-11-02 | — | — | US | disclosed |
| US-7745653-B2 | Fluorochemical compounds having pendent silyl groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-06-29 | — | — | US | disclosed |
| US-20100105828-A1 | FLUOROCHEMICAL URETHANE COMPOUNDS HAVING PENDENT SILYL GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-04-29 | — | — | US | disclosed |
| EP-2134729-A2 | FLUOROCHEMICAL COMPOUNDS HAVING PENDENT SILYL GROUPS | 3M Innovative Properties Company (US) | 2009-12-23 | — | — | EP | disclosed |
| EP-2121789-A1 | FLUOROCHEMICAL URETHANE COMPOUNDS HAVING PENDENT SILYL GROUPS | 3M Innovative Properties Company (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008112400-A2 | FLUOROCHEMICAL COMPOUNDS HAVING PENDENT SILYL GROUPS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-09-18 | — | — | WO | disclosed |
| US-20080220264-A1 | FLUOROCHEMICAL COMPOUNDS HAVING PENDENT SILYL GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2008-09-11 | — | — | US | disclosed |
| WO-2008076639-A1 | FLUOROCHEMICAL URETHANE COMPOUNDS HAVING PENDENT SILYL GROUPS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080220264-A1 | FLUOROCHEMICAL COMPOUNDS HAVING PENDENT SILYL GROUPS | SGMS2, SGMS1, NOTUM | THRB 4625/4885LMNA 1034/4885ALDH1A1 1770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.